Pouvreau N, Tandonnet J, Tandonnet O, Renesme L
Unité de néonatalogie-soins intensifs, centre Aliénor d'Aquitaine, centre hospitalier Pellegrin CHU de Bordeaux, place Amélie-Raba-Léon, 33000 Bordeaux, France.
Équipe ressource régionale en soins palliatifs pédiatriques d'Aquitaine, place Amélie-Raba-Léon, 33000 Bordeaux, France.
Arch Pediatr. 2017 Sep;24(9):850-859. doi: 10.1016/j.arcped.2017.06.009. Epub 2017 Aug 12.
Subcutaneous hydration (hypodermoclysis) and drug administration is a widely used method of analgesic therapy in adult palliative care medicine. Very little is known about its use in neonatal medicine. Evidence-based guidelines do not exist due to a lack of data. In this study, the advantages of subcutaneous analgesic therapy in terms of comfort in neonatal palliative care situations were investigated.
This report details the results of a systematic review associated with a survey in neonatal intensive care units (NICUs) and pediatric palliative care departments (PPCTs) in France.
No article was available in the Medline database. In Google, we found six guidelines that described the use of the subcutaneous route in the pediatric palliative population. The participation rate in the survey was approximately 83 % for French NICUs and 74 % for PPCTs. Eleven percent of NICUs and 27 % of PPCTs had already used subcutaneous drug administration for palliative care, mainly for analgesia and terminal sedation. Limiting factors of its use were mainly alternative options and the lack of data. Nevertheless, 76 % of NICUs and 73 % of PPCTs expressed an interest in the use of the subcutaneous route in NICUs. Ninety-one percent of French NICUs and 80 % of PPCTs were interested in elaborating a protocol using the subcutaneous route for analgesia, anxiolysis, or terminal sedation.
The subcutaneous route can be advantageous for comfort care in the neonatal palliative population. Studies are needed to define the modalities, pharmacodynamics, and pharmacokinetics of therapeutics in this population.
皮下补液(皮下输液法)和给药是成人姑息治疗医学中广泛使用的镇痛治疗方法。关于其在新生儿医学中的应用知之甚少。由于缺乏数据,尚无循证指南。本研究调查了皮下镇痛治疗在新生儿姑息治疗情况下的舒适性优势。
本报告详细介绍了一项与法国新生儿重症监护病房(NICU)和儿科姑息治疗科室(PPCT)调查相关的系统评价结果。
Medline数据库中没有相关文章。在谷歌上,我们找到了六项描述皮下途径在儿科姑息治疗人群中应用的指南。法国NICU的调查参与率约为83%,PPCT的参与率为74%。11%的NICU和27%的PPCT已经将皮下给药用于姑息治疗,主要用于镇痛和临终镇静。其使用的限制因素主要是替代选择和数据缺乏。尽管如此,76%的NICU和73%的PPCT表示有兴趣在NICU中使用皮下途径。91%的法国NICU和80%的PPCT有兴趣制定使用皮下途径进行镇痛、抗焦虑或临终镇静的方案。
皮下途径对新生儿姑息治疗人群的舒适护理可能具有优势。需要开展研究来确定该人群治疗的方式、药效学和药代动力学。